{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:35:36Z","timestamp":1791387336275,"version":"4.3.3"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Fertility Clinic, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>The global increase in frozen-thawed embryo transfer (FET) cycles has led to a critical evaluation of endometrial preparation methods. While various approaches such as natural or modified natural cycle FET, stimulated FET by use of letrozole (LTZ) and\/or gonadotrophins, and artificial cycle (AC) FET, are currently in clinical use, the optimal regimen remains unclear, particularly for women with oligo-anovulation or polycystic ovarian syndrome (PCOS). This systematic review and meta-analysis compares LTZ FET with AC FET regarding reproductive, obstetric, and neonatal outcomes in these populations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OBJECTIVE AND RATIONALE<\/jats:title>\n                  <jats:p>The aim was to determine whether LTZ FET improves reproductive, obstetric, and neonatal outcomes compared to AC FET in women with ovulatory disorders and\/or PCOS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SEARCH METHODS<\/jats:title>\n                  <jats:p>A comprehensive search of MEDLINE, Cochrane, and ClinicalTrials.gov databases was conducted for studies until June 2024. Eligible studies included women with ovulatory disorders and\/or PCOS, comparing LTZ FET to AC FET. Data extraction focused on the live birth rate (LBR), ongoing pregnancy rate, clinical pregnancy rate, pregnancy loss rate, hypertensive disorders of pregnancy (HDP), gestational diabetes mellitus (GDM), birth weight, small for gestational age (SGA), large for gestational age (LGA), and congenital malformations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OUTCOMES<\/jats:title>\n                  <jats:p>The search identified 74 studies, and included 15 observational studies and two randomized controlled trials (RCTs) meeting the inclusion criteria; the studies encompassed a total of 8307 women treated with LTZ FET (\u00b1additional gonadotropin) and 16,940 women treated with AC FET. The meta-analysis comparing LTZ FET to AC FET demonstrated a modest yet statistically significant increase in the odds of LB (OR 1.37, 95% CI 1.21\u20131.56), corresponding to an 8% risk difference (95% CI 4%\u201311%). The one RCT that reported on LB yielded a similar LBR for LTZ FET and AC FET, thus did not support a better outcome after LTZ FET. Pregnancy losses, defined either as a loss following a positive serum hCG or following a clinical pregnancy, were compared between LTZ FET and AC FET. The meta-analysis indicated a reduction in the odds of PL with LTZ FET (OR 0.63, 95% CI 0.51\u20130.78). However, the two RCTs reporting this outcome exhibited high heterogeneity, introducing uncertainty of the result. LTZ FET was associated with lower risks of HDP (OR 0.70, 95% CI 0.58\u20130.84) and LGA (OR 0.75, 95% CI 0.67\u20130.85), but no significant differences were observed for GDM or SGA. For all outcomes, the certainty of evidence was low.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS<\/jats:title>\n                  <jats:p>LTZ FET may offer a modest improvement in reproductive outcomes and a lower risk of some obstetric complications compared to AC FET, particularly in women with oligo-anovulation. However, the quality of evidence remains low, and more well-designed RCTs are needed to confirm these findings. While awaiting further data, LTZ FET may be recommended as a viable alternative to AC FET for women with ovulatory disorders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>PROSPERO\u2014CRD42023395117.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humupd\/dmaf011","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:51:57Z","timestamp":1748307117000},"page":"445-463","source":"Crossref","is-referenced-by-count":15,"title":["Reproductive outcomes after letrozole stimulated versus artificial frozen-thawed embryo transfer cycles in women with PCOS and\/or oligo-anovulation: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2005-7277","authenticated-orcid":false,"given":"Nathalie S\u00f8derhamn","family":"B\u00fclow","sequence":"first","affiliation":[{"name":"The Fertility Clinic, Department of Gynaecology, Fertility, and Obstetrics, Rigshospitalet, Copenhagen University Hospital , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Louise","family":"Wissing","sequence":"additional","affiliation":[{"name":"Aleris Fertility, Aleris Hospitals , Soeborg,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Macklon","sequence":"additional","affiliation":[{"name":"London Women\u2019s Clinic , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8340-104X","authenticated-orcid":false,"given":"Anja","family":"Pinborg","sequence":"additional","affiliation":[{"name":"The Fertility Clinic, Department of Gynaecology, Fertility, and Obstetrics, Rigshospitalet, Copenhagen University Hospital , Copenhagen,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"L\u00f8ssl","sequence":"additional","affiliation":[{"name":"The Fertility Clinic, Department of Gynaecology, Fertility, and Obstetrics, Rigshospitalet, Copenhagen University Hospital , Copenhagen,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"2025090301515844200_dmaf011-B1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s43032-023-01404-8","article-title":"Comparison of letrozole and clomiphene citrate in pregnancy outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Abu-Zaid","year":"2024","journal-title":"Reprod Sci"},{"key":"2025090301515844200_dmaf011-B98115482","doi-asserted-by":"crossref","first-page":"83","DOI":"10.29252\/ijrm.15.2.83","article-title":"Can letrozole plus HMG protocol improve pregnancy outcomes in frozen-thawed embryo transfer? An RCT","volume":"15","author":"Aleyasin","year":"2017","journal-title":"IJRM"},{"key":"2025090301515844200_dmaf011-B2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/jcm10040703","article-title":"Ovulatory-based FET cycles may achieve higher pregnancy rates in the general population and among anovulatory women","volume":"10","author":"Aslih","year":"2021","journal-title":"J Clin Med"},{"key":"2025090301515844200_dmaf011-B3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1530\/RAF-21-0044","article-title":"Retrospective cohort study on preparation regimens for frozen embryo transfer","volume":"2","author":"Atkinson","year":"2021","journal-title":"Reprod Fertil"},{"key":"2025090301515844200_dmaf011-B4","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/humrep\/deac073","article-title":"Obstetric and perinatal outcomes following programmed compared to natural frozen-thawed embryo transfer cycles: a systematic review and meta-analysis","volume":"37","author":"Busnelli","year":"2022","journal-title":"Hum Reprod"},{"key":"2025090301515844200_dmaf011-B40","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1055\/a-1202-2059","article-title":"Pregnancy Outcomes Following Letrozole Use in Frozen-thawed Embryo Transfer Cycles: A Systematic Review and Meta-analysis","volume":"80","author":"Chen","year":"2020","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"2025090301515844200_dmaf011-B5","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090301515844200_dmaf011-B6","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1008095","article-title":"Reproductive technologies and the risk of birth defects","volume":"366","author":"Davies","year":"2012","journal-title":"N Engl J Med"},{"key":"2025090301515844200_dmaf011-B7","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/humrep\/dead197","article-title":"ART in Europe, 2019: results generated from European registries by ESHRE\u2020","volume":"38","author":"European IVF Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE)","year":"2023","journal-title":"Hum Reprod"},{"key":"2025090301515844200_dmaf011-B39","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/humupd\/dms019","article-title":"Health and fertility in World Health Organization group 2 anovulatory women","volume":"18","author":"ESHRE Capri Workshop Group","year":"2012","journal-title":"Hum Reprod Update"},{"key":"2025090301515844200_dmaf011-B8","first-page":"CD006359","article-title":"Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes","volume":"10","author":"Glujovsky","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090301515844200_dmaf011-B9","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.fertnstert.2022.06.013","article-title":"Pregnancy outcomes after frozen-thawed embryo transfer using letrozole ovulation induction, natural, or programmed cycles","volume":"118","author":"Godiwala","year":"2022","journal-title":"Fertil Steril"},{"key":"2025090301515844200_dmaf011-B10","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/bmj.38636.593461.68","article-title":"Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources","volume":"331","author":"Greenhalgh","year":"2005","journal-title":"BMJ"},{"key":"2025090301515844200_dmaf011-B11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12884-022-04728-6","article-title":"The effect of mildly stimulated cycle versus artificial cycle on pregnancy outcomes in overweight\/obese women with PCOS prior to frozen embryo transfer: a retrospective cohort study","volume":"22","author":"Guan","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025090301515844200_dmaf011-B12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.fertnstert.2023.07.003","article-title":"Risk of congenital malformations in live-born singletons conceived after intracytoplasmic sperm injection: a Nordic study from the CoNARTaS group","volume":"120","author":"Henningsen","year":"2023","journal-title":"Fertil Steril"},{"key":"2025090301515844200_dmaf011-B13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2025090301515844200_dmaf011-B14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12958-020-00675-z","article-title":"The effect of letrozole versus artificial hormonal endometrial preparation on pregnancy outcome after frozen-thawed embryos transfer cycles: a randomized clinical trial","volume":"18","author":"Hosseini-Najarkolaei","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"2025090301515844200_dmaf011-B15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cen.12280","article-title":"Letrozole stimulation in endometrial preparation for cryopreserved-thawed embryo transfer in women with polycystic ovarian syndrome: a pilot study","volume":"80","author":"Hu","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025090301515844200_dmaf011-B5222923","first-page":"1233","article-title":"[Clinical effect of letrozole on the ovulation induction in endometrial preparation for frozen-thawed embryo transfer]","volume":"37","author":"Li","year":"2012","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"2025090301515844200_dmaf011-B16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00404-013-3044-0","article-title":"Letrozole ovulation induction: an effective option in endometrial preparation for frozen-thawed embryo transfer","volume":"289","author":"Li","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"2025090301515844200_dmaf011-B73486886","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.2147\/DDDT.S212235","article-title":"Pregnancy And Neonatal Outcomes Of hMG Stimulation With Or Without Letrozole In Endometrial Preparation For Frozen-Thawed Embryo Transfer In Ovulatory Women: A Large Retrospective Cohort Study","volume":"13","author":"Lin","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"2025090301515844200_dmaf011-B17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/GCO.0000000000000867","article-title":"The future of frozen-thawed embryo transfer in hormone replacement therapy cycles","volume":"35","author":"L\u00f8ssl","year":"2023","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2025090301515844200_dmaf011-B18","doi-asserted-by":"crossref","first-page":"987813","DOI":"10.3389\/fendo.2022.987813","article-title":"Ovulation induction regimens are associated with a higher rate of livebirth after frozen single-blastocyst transfer among women with polycystic ovary syndrome","volume":"13","author":"Niu","year":"2022","journal-title":"Front Endocrinol"},{"key":"2025090301515844200_dmaf011-B19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.fertnstert.2012.12.001","article-title":"Congenital anomalies after assisted reproductive technology","volume":"99","author":"Pinborg","year":"2013","journal-title":"Fertil Steril"},{"key":"2025090301515844200_dmaf011-B20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"2025090301515844200_dmaf011-B21","volume-title":"GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations","author":"Sch\u00fcnemann","year":"2014"},{"key":"2025090301515844200_dmaf011-B22","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2025090301515844200_dmaf011-B23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14647273.2021.1961313","article-title":"Clinical pregnancy rates among anovulatory and oligoovulatory women after letrozole versus hormone replacement therapy in frozen-thawed embryo transfer cycles","author":"Sharon-Weiner","year":"2023","journal-title":"Hum Fertil (Camb)"},{"key":"2025090301515844200_dmaf011-B24","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2025090301515844200_dmaf011-B6029943","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/humrep\/dex066","article-title":"Pregnancy and neonatal outcomes following letrozole use in frozen-thawed single embryo transfer cycles","volume":"32","author":"Tatsumi","year":"2017","journal-title":"Hum Reprod"},{"key":"2025090301515844200_dmaf011-B25","first-page":"971","article-title":"Strong early impact of letrozole on ovulation induction outperforms clomiphene citrate in polycystic ovary syndrome","volume":"17","author":"Vajna","year":"2024","journal-title":"Pharm Basel Switz"},{"key":"2025090301515844200_dmaf011-B26","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/humrep\/deac125","article-title":"Should any use of artificial cycle regimen for frozen-thawed embryo transfer in women capable of ovulation be abandoned: yes, but what\u2019s next for FET cycle practice and research?","volume":"37","author":"von Versen-H\u00f6ynck","year":"2022","journal-title":"Hum Reprod"},{"key":"2025090301515844200_dmaf011-B27","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/HYPERTENSIONAHA.118.12043","article-title":"Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a corpus luteum","volume":"73","author":"von Versen-H\u00f6ynck","year":"2019","journal-title":"Hypertension"},{"key":"2025090301515844200_dmaf011-B28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/1933719118776792","article-title":"Effect of mode of conception on maternal serum relaxin, creatinine, and sodium concentrations in an infertile population","volume":"26","author":"von Versen-H\u00f6ynck","year":"2019","journal-title":"Reprod Sci"},{"key":"2025090301515844200_dmaf011-B29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12958-023-01154-x","article-title":"Letrozole-stimulated endometrial preparation protocol is a superior alternative to hormone replacement treatment for frozen embryo transfer in women with polycystic ovary syndrome, a cohort study","volume":"21","author":"Wang","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"2025090301515844200_dmaf011-B30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejogrb.2024.01.004","article-title":"What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles among anovulatory women? A retrospective cohort study","volume":"294","author":"Wen","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025090301515844200_dmaf011-B8323782","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s10815-016-0787-0","article-title":"Preparation of endometrium for frozen embryo replacement cycles: a systematic review and meta-analysis","volume":"33","author":"Yarali","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"2025090301515844200_dmaf011-B31","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/AOG.0000000000005367","article-title":"Letrozole during frozen embryo transfer in women with polycystic ovarian syndrome: a randomized controlled trial","volume":"142","author":"Yuan","year":"2023","journal-title":"Obstet Gynecol"},{"key":"2025090301515844200_dmaf011-B32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/09513590.2020.1867976","article-title":"Stimulated cycle versus artificial cycle for frozen embryo transfer in patients with polycystic ovary syndrome: a meta-analysis","volume":"37","author":"Zeng","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"2025090301515844200_dmaf011-B33","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s10815-023-02956-z","article-title":"Letrozole use in vitrified single-blastocyst transfer cycles is associated with lower risk of large for gestational age infants in patients with polycystic ovary syndrome","volume":"40","author":"Zhang","year":"2023","journal-title":"J Assist Reprod Genet"},{"key":"2025090301515844200_dmaf011-B34","doi-asserted-by":"crossref","first-page":"664072","DOI":"10.3389\/fendo.2021.664072","article-title":"Comparison of pregnancy and neonatal outcomes of single frozen blastocyst transfer between letrozole-induction and HRT cycles in patients with abnormal ovulation","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol"},{"key":"2025090301515844200_dmaf011-B35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fertnstert.2019.04.014","article-title":"Letrozole use during frozen embryo transfer cycles in women with polycystic ovary syndrome","volume":"112","author":"Zhang","year":"2019","journal-title":"Fertil Steril"},{"key":"2025090301515844200_dmaf011-B36","doi-asserted-by":"crossref","first-page":"837731","DOI":"10.3389\/fendo.2022.837731","article-title":"Comparison of perinatal outcomes of letrozole-induced ovulation and hormone replacement therapy protocols in patients with abnormal ovulation undergoing frozen-thawed embryo transfer: a propensity score matching analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol"},{"key":"2025090301515844200_dmaf011-B37","doi-asserted-by":"crossref","first-page":"59.e1","DOI":"10.1016\/j.ajog.2021.01.024","article-title":"Letrozole-induced frozen embryo transfer cycles are associated with a lower risk of hypertensive disorders of pregnancy among women with polycystic ovary syndrome","volume":"225","author":"Zhang","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"2025090301515844200_dmaf011-B38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12958-022-00931-4","article-title":"Systematic review update and meta-analysis of randomized and non-randomized controlled trials of ovarian stimulation versus artificial cycle for endometrial preparation prior to frozen embryo transfer in women with polycystic ovary syndrome","volume":"20","author":"Zhang","year":"2022","journal-title":"Reprod Biol Endocrinol"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humupd\/article-pdf\/31\/5\/445\/63363041\/dmaf011.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humupd\/article-pdf\/31\/5\/445\/63363041\/dmaf011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T05:52:11Z","timestamp":1756878731000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humupd\/article\/31\/5\/445\/8150992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,26]]},"published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmaf011","relation":{},"ISSN":["1355-4786","1460-2369"],"issn-type":[{"value":"1355-4786","type":"print"},{"value":"1460-2369","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,5,26]]}}}